ON-DEMAND: ANTINEOPLASTIC THERAPY AND IMMUNOTHERAPY COURSE

The On-Demand UPMC Antineoplastic Therapy and Immunotherapy Course contains the elements of the live four-day activity but allows the participant to access the learning on their own schedule.  Those enrolled in the course are required to complete all video modules containing lectures from the four-day course.  Once all videos have been viewed, complete the evaluation to receive 22.75 continuing education credits. Notify your manager to contact course director to schedule the learner for the Antineoplastic Therapy and Immunotherapy Course Exam for On-Demand Course. Upon passing the test, with a score of 80% or greater the learner will receive certificate of completion for the activity.

The course components include: Video Lectures, Course Evaluation and Antineoplastic Therapy and Immunotherapy Course Test. 

To enroll, choose Register and scroll to the bottom of the page and choose Enroll.

Target Audience

Licensed healthcare professionals working in Oncology or with Oncology Patients including Registered Nurses, Nurse Practitioners, Physican Assistants, and Pharmacists.  

Learning Objectives

After completing the activity, the learner will be able to:

Compare and contrast the mechanism of action between antineoplastic therapy and immunotherapy.

 Recall the side effect profiles for the different classes of antineoplastic agents and immunotherapies.

 Recall nursing care considerations for patients receiving antineoplastic therapy and immunotherapy.

 Compare and contrast the mechanisms of action, side effect profile, complications, and management of side effects for patients receiving novel treatment modalities including Car T-cell therapy, BiTE therapy, and TIL cell therapy.

 Describe the role that chemotherapy protectants play in the treatment of cancer.

 Recall patient barriers to adherence of oral cancer medications.

 Apply principles of antineoplastic therapy drug administration in calculating drug doses to include calculation of body surface area (BSA), absolute neutrophil count (ANC), creatinine clearance (Cr Cl) and carboplatin dosing.

 Describe the steps to ensure safe administration of antineoplastic and immunotherapy agents.  

 Identify assessment priorities to effectively manage patient symptoms, dose-limiting toxicities, and adverse effects of antineoplastic therapy and immunotherapy.

 Recognize relevant resources for proper use of personal protective equipment (PPE) and excretion precautions.

 Prioritize the appropriate interventions for the management of hypersensitivity reactions.

 Describe the appropriate interventions for the management of vesicant extravasation.

 Discuss the differences between cancer genetics and cancer genomics.

 Identify the role that growth factors play when treating oncology patients.

 Recall strategies to prevent medication errors.

.

Course summary
Available credit: 
  • 22.75 AAPA Category I CME
  • 22.75 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 22.75 Attendance
Course opens: 
09/06/2024
Course expires: 
10/04/2024

Lecture

Speaker                                      

Length                       

Welcome and Course Overview

Lynne OConnor

20 min

Principles of Antineoplastic Drug Therapy

Earnie Sanchez

40 min 

Administration

Markie Rearick

75 min

Extravasation

Nancy Birus

30 min

Hypersensitivity

Alyssa Owens

40 min

Error Prevention

Amy DiMaggio

40 min

Build Your Knowledge

Lynne OConnor

50 min

Alkylating Agents

Trish Seaman

50 min

Chemotherapy Protectants

Lynne OConnor

35 min

Genetics vs. Genomics

Melissa Bourdius

40 min

Antimetabolites

Tim George

60 min

Antitumor Antibodies

Steve Morelli

60 min

Cytokines and Vaccines

Tim George

50 min

Growth Factors

Emily Mueseler

30 min

Organ Toxicities

Linda Pfeiffer

60 min

Misc Agents

Tim Brenner

120 min

Hormone Therapy: Breast

Courtney Stetor

30 min

Hormone Therapy: Prostate

Tom Boyer

40 min

Adoptive cellular therapy and BiTE therapy

Shrina Duggal

60 min

Monoclonal Antibodies Part 1

Melissa Bastacky

80 min

Monoclonal Antibodies Part 2

Melissa Bastacky

55 min

Tyrosine Kinase Inhibitors Part 1

Amanda Agnew

60 min

Tyrosine Kinase Inhibitors Part 2

Jason Steele

65 min

Oral Adherence

Nancy Birus

40 min

Plant Alkaloids

Marissa Lamary

30 min

Homework Review

Lynne OConnor

30 min

Case Study

Maura Miller

30 min

Post Course Instructions

Lynne OConnor

30 min

 

UPMC Hillman Cancer Center
Pittsburgh, PA
United States

Amanda Agnew, PharmD, BCPS, BCOP

Clinical Oncology Pharmacist

UPMC Hillman Cancer Center

 

Melissa Bastacky, PharmD, BCOP

Clinical Pharmacy Specialist

UPMC Hillman Cancer Center

 

Nancy Birus MSN, RN, OCN

Clinical Education Specialist

UPMC Hillman Cancer Center

 

Melissa K. Bourdius, MS, CGC

Genetics Counselor

Special Genetic Counsel

UPMC Magee-Womens Hospital

 

Tom G. Boyer, PA-C

Physician Assistant

University of Pittsburgh Physicians

 

Tim Brenner, PharmD, BCOP

Clinical Pharmacy Specialist

UPMC Hillman Cancer Center

 

 

Amy DiMaggio, MSN, RN, OCN

Clinical Education Specialist

UPMC Hillman Cancer Center

 

Shrina Duggal, PharmD, BCOP

Lead Clinical Oncology Pharmacist

UPMC Hillman Cancer Center

 

Timothy George, PharmD, BCOP

Clinical Pharmacy Specialist

UPMC Hillman Cancer Center

 

Marissa Lamary, PA-C

Physician Assistant

UPMC Hillman Cancer Center

UPMC Shadyside

 

Maura Miller DNP, APRN, FNP-BC, OCN

Clinical Education Specialist

UPMC Hillman Cancer Center

 

Steve Moretti, PharmD

Oncology Consultant Pharmacist

Investigational Drug Service Pharmacy

UPMC Hillman Cancer Center Shadyside

 

Emily Mueseler, MPAS, PA-C

Physician Assistant

UPMC Hillman Cancer Center

 

Lynne O’Connor, MSN, RN, OCN

Clinical Education Specialist

UPMC Hillman Cancer Center

 

Alyssa Owens, MPAS, PA-C                                                   

Physician Assistant

UPMC Hillman Cancer Center

 

Linda Pfeifer, CRNP, RN                     

Nurse Practitioner

UPMC Hillman Cancer Center

 

Markie Rearick, MSN, RN, BMTCN

Clinical Education Specialist

UPMC Shadyside

 

Ernest M. Sanchez, Pharm.D.

Lead Pharmacist of Oncology Operations, Department of Pharmacy

UPMC Shadyside Hospital

 

Jason Steele, PharmD, BCOP

Oncology Clinical Pharmacist

UPMC Hillman Cancer Center

 

Courtney Stetor, MPAS PA-C

Physician Assistant

UPMC Hillman Cancer Center

 

 

 

 

Disclaimer Statement:

The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine.  Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 

Physician Assistant (AAPA)
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 22.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
 

Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 22.75 contact hours.
 

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Available Credit

  • 22.75 AAPA Category I CME
  • 22.75 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 22.75 Attendance
Please login or register to take this course.